Conditional survival and changing risk profile in patients with gliosarcoma.

Area of Science:

• Neuro-oncology
• Cancer epidemiology
• Biostatistics

Background:

• Conditional survival (CS) offers valuable insights beyond initial diagnosis for cancer patients.
• Gliosarcoma (GSM) is a rare and aggressive brain tumor with limited survival data.
• Evaluating CS in GSM patients can refine prognostic assessments.

Purpose of the Study:

• To assess conditional survival (CS) in patients diagnosed with gliosarcoma (GSM).
• To develop a nomogram model integrating CS for predicting survival probabilities in GSM patients.
• To enhance risk stratification and patient counseling for GSM.

Main Methods:

• Retrospective analysis of 1,015 GSM patients from the SEER database (2000-2017).
• Calculation of CS using the formula CS(y|x) = S(y+x)/S(x).
• Prognostic factor identification via univariate Cox regression, best subset regression (BSR), and LASSO, followed by multivariable Cox regression.
• Development and validation of a CS-nomogram using discrimination and calibration assessments.

Main Results:

• CS analysis revealed increasing 5-year survival probabilities: 5% at diagnosis to 74% after 4 years.
• Five key prognostic factors identified: age, tumor stage, tumor size, radiotherapy, and chemotherapy.
• The developed CS-nomogram demonstrated good performance in both training and validation cohorts.
• The CS-nomogram effectively stratified GSM patient risk.

Conclusions:

• This study provides the first nationwide delineation of conditional survival for gliosarcoma patients.
• A CS-nomogram offers a valuable tool for predicting survival and guiding clinical decisions in GSM management.
• The nomogram can significantly improve patient counseling and risk stratification strategies.